CONTEXT: Understanding the role of insulin resistance in type 1 diabetes may lead to new prevention strategies. Estimates of insulin resistance in first-degree relatives of those with type 1 diabetes may be obtained using the minimal model of glucose kinetics incorporating a population approach. OBJECTIVE: The objective of the study was to explore parameters contributing to glucose homeostasis in a cross-sectional study of first-degree relatives across a wide age range. DESIGN: Insulin sensitivity (SI) was assessed using the minimal model of glucose kinetics after an oral glucose tolerance test combined with nonlinear mixed-effects modeling. Beta-cell function was measured from the insulinogenic index at 30 min (IGI(30)). Disposition index (DI) was estimated as the product of SI and IGI(30). SETTING: The study was conducted at an academic center. SUBJECTS: Subjects included 1241 first-degree relatives (aged 2-75 yr). RESULTS: SI was found to be negatively correlated with age, whereas IGI(30) increased until young adulthood. The increase IGI(30) was apparently insufficient to compensate for the insulin resistance because DI decreased linearly at the rate of 0.035 (10(-2) min(-1) mmol(-1) liter per year) after young adulthood. Both IGI(30) and DI were significantly lower in those with vs. without autoantibodies, whereas there was no difference between these groups with respect to SI. CONCLUSIONS: Beta-cell function, adjusted for age-related insulin resistance, decreases throughout life in first-degree relatives. This deterioration may be exacerbated in the presence of autoantibodies. Oral glucose tolerance test data combined with a nonlinear mixed-effect modeling population approach may be a useful technique to evaluate SI and secretion in a population.
CONTEXT: Understanding the role of insulin resistance in type 1 diabetes may lead to new prevention strategies. Estimates of insulin resistance in first-degree relatives of those with type 1 diabetes may be obtained using the minimal model of glucose kinetics incorporating a population approach. OBJECTIVE: The objective of the study was to explore parameters contributing to glucose homeostasis in a cross-sectional study of first-degree relatives across a wide age range. DESIGN:Insulin sensitivity (SI) was assessed using the minimal model of glucose kinetics after an oral glucose tolerance test combined with nonlinear mixed-effects modeling. Beta-cell function was measured from the insulinogenic index at 30 min (IGI(30)). Disposition index (DI) was estimated as the product of SI and IGI(30). SETTING: The study was conducted at an academic center. SUBJECTS: Subjects included 1241 first-degree relatives (aged 2-75 yr). RESULTS: SI was found to be negatively correlated with age, whereas IGI(30) increased until young adulthood. The increase IGI(30) was apparently insufficient to compensate for the insulin resistance because DI decreased linearly at the rate of 0.035 (10(-2) min(-1) mmol(-1) liter per year) after young adulthood. Both IGI(30) and DI were significantly lower in those with vs. without autoantibodies, whereas there was no difference between these groups with respect to SI. CONCLUSIONS: Beta-cell function, adjusted for age-related insulin resistance, decreases throughout life in first-degree relatives. This deterioration may be exacerbated in the presence of autoantibodies. Oral glucose tolerance test data combined with a nonlinear mixed-effect modeling population approach may be a useful technique to evaluate SI and secretion in a population.
Authors: Andreas Fritsche; Alexander Madaus; Norbert Stefan; Otto Tschritter; Elke Maerker; Anna Teigeler; Hans Häring; Michael Stumvoll Journal: Diabetes Date: 2002-02 Impact factor: 9.461
Authors: M Pietropaolo; D J Becker; R E LaPorte; J S Dorman; S Riboni; W A Rudert; S Mazumdar; M Trucco Journal: Diabetologia Date: 2002-01 Impact factor: 10.122
Authors: T Kimpimäki; P Kulmala; K Savola; P Vähäsalo; H Reijonen; J Ilonen; H K Akerblom; M Knip Journal: J Clin Endocrinol Metab Date: 2000-03 Impact factor: 5.958
Authors: Rita Basu; Elena Breda; Ann L Oberg; Claudia C Powell; Chiara Dalla Man; Ananda Basu; Janet L Vittone; George G Klee; Puneet Arora; Michael D Jensen; Gianna Toffolo; Claudio Cobelli; Robert A Rizza Journal: Diabetes Date: 2003-07 Impact factor: 9.461
Authors: K Müssig; M Heni; C Thamer; K Kantartzis; F Machicao; N Stefan; A Fritsche; H-U Häring; H Staiger Journal: Diabetologia Date: 2009-11-29 Impact factor: 10.122
Authors: Jay M Sosenko; Jeffrey Mahon; Lisa Rafkin; John M Lachin; Heidi Krause-Steinrauf; Jeffrey P Krischer; David Cuthbertson; Jerry P Palmer; Clinton Thompson; Carla J Greenbaum; Jay S Skyler Journal: Pediatr Diabetes Date: 2011-03 Impact factor: 4.866
Authors: Peter P Reese; Roy D Bloom; Justine Shults; Arwin Thomasson; Adam Mussell; Sylvia E Rosas; Kirsten L Johansen; Peter Abt; Matthew Levine; Arthur Caplan; Harold I Feldman; Jason Karlawish Journal: Transplantation Date: 2014-01-27 Impact factor: 4.939
Authors: David A Baidal; Megan Warnock; Ping Xu; Susan Geyer; Jennifer B Marks; Antoinette Moran; Jay Sosenko; Carmella Evans-Molina Journal: J Clin Endocrinol Metab Date: 2022-07-14 Impact factor: 6.134
Authors: Rita Upreti; Katherine A Hughes; Dawn E W Livingstone; Calum D Gray; Fiona C Minns; David P Macfarlane; Ian Marshall; Laurence H Stewart; Brian R Walker; Ruth Andrew Journal: J Clin Endocrinol Metab Date: 2014-05-13 Impact factor: 5.958